Product Highlight - Femiest

08 Sep 2022
Product Highlight - Femiest
Active ingredient: Estradiol hemihydrate.

Indication: Vaginal atrophy due to oestrogen deficiency in postmenopausal women.

Dosage & Administration: Administer intravaginally as a local oestrogen therapy by use of applicator. Initially 1 tab once daily for 2 wk. Maintenance dose: 1 tab twice wkly. May start treatment on any convenient day.

Related MIMS Drugs

Editor's Recommendations